Clinical Trials Logo

Essential Tremor clinical trials

View clinical trials related to Essential Tremor.

Filter by:

NCT ID: NCT01864525 Completed - Voice Tremor Clinical Trials

Effects of Octanoic Acid for Treatment of Essential Voice Tremor

Start date: July 2013
Phase: Phase 1/Phase 2
Study type: Interventional

Essential voice tremor is a neurological condition that produces a regular, shaking quality in the voice. One form of drug treatment that produces some improvement in tremor of the hands is octanoic acid, which is a food additive that is similar to alcohol. Research suggests that octanoic acid may reduce tremor in the hands/arms with few side effects and no intoxication effects. This study will determine whether octanoic acid may be useful for reducing tremor when it affects the voice. Researchers are hypothesizing that octanoic acid will reduce the effects of tremor on the voice.

NCT ID: NCT01827904 Completed - Essential Tremor Clinical Trials

ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors

Start date: May 2013
Phase: N/A
Study type: Interventional

The objective of this prospective, randomized, double-blind (to subjects, local site's blinded assessor and Tremor Core Lab assessors), crossover, multi-site, two-arm study (ExAblate treated arm Vs ExAblate Sham treated control arm) is to test the efficacy of treatment using the ExAblate Transcranial System and to further demonstrate safety in medication-refractory tremor in subjects with essential tremor (ET).

NCT ID: NCT01809613 Completed - Parkinson Disease Clinical Trials

Functional Magnetic Resonance Imaging (fMRI) During Deep Brain Stimulation (DBS) to Treat Parkinson's Disease

Start date: March 2013
Phase: N/A
Study type: Observational

This study is investigating the usefulness of using functional magnetic resonance imaging (fMRI) to monitor brain activation during deep brain stimulation for Parkinson's Disease, Essential tremor, dystonia, OCD, depression, pain, Tourette's syndrome, and epilepsy. The study may determine the relationship between patterns of brain activation and therapeutic outcome and/or side effects.

NCT ID: NCT01764815 Completed - Parkinson's Disease Clinical Trials

Evaluation of Directional Stimulation During the Implantation of Deep Brain Stimulation (DBS) Leads

Start date: December 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to provide proof-of-concept that directional stimulation, in an intraoperative setting, is perceivable in a subject and is different from omnidirectional stimulation. The tests will be performed using a dedicated DBS lead connected to external neurostimulator.

NCT ID: NCT01705301 Completed - Parkinson's Disease Clinical Trials

Neurotransmitter Measurements Using (WINCS) During Deep Brain Stimulation Neurosurgery

Start date: January 2010
Phase: N/A
Study type: Observational

In this study, the investigators will monitor extracellular neurotransmitter levels using a probe that is able to perform real time electrochemical detection during deep brain stimulation surgery. The overall question this study is designed to answer is: Are there neurotransmitters released during deep brain stimulation?

NCT ID: NCT01698450 Completed - Parkinson's Disease Clinical Trials

Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement Disorders

Start date: November 2012
Phase: Phase 1
Study type: Interventional

The aim of this study is to asses the efficacy and the clinical safety of the transcranial magnetic resonance guided high intensity focused ultrasound system ExAblate 4000, InSightec Ltd. for functional neurosurgery in the treatment of movement disorders. The treatments to be conducted in this study are non-invasive, i.e. without opening the skull, and will create microthalamotomies in specific target areas such as thalamus, subthalamus and pallidum. The data obtained in this study will be used to evaluate the basic safety aspects of this new treatment technology and will serve as a basis for the clinical introduction of MR-guided ultrasound neurosurgery.

NCT ID: NCT01602042 Completed - Essential Tremor Clinical Trials

Adaptive Portable Essential Tremor Monitor

Start date: May 2012
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the utility of a portable motion sensor-based system designed to monitor essential tremor (ET) to better prescribe therapy to minimize symptoms and expand care for ET patients.

NCT ID: NCT01579435 Completed - Essential Tremor Clinical Trials

Experimental Therapeutics in Essential Tremor Using Transcranial Direct Current Stimulation

ELECTRE
Start date: April 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether transcranial direct current stimulation (tDCS) delivered over the motor cortex or the cerebellum can improve essential tremor and to identify the cerebral mechanisms involved in these potential effects.

NCT ID: NCT01547481 Completed - Clinical trials for REM Sleep Behavior Disorder

MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.

Start date: December 2011
Phase:
Study type: Observational

This proposal is focused on developing a reliable, valid, and reproducible imaging techniques and statistical methodology for segregation of various forms of Parkinsonism from healthy adults without Parkinsonism.

NCT ID: NCT01534650 Completed - Parkinson's Disease Clinical Trials

Movement Disorder Quantification Algorithm Development

Start date: February 2012
Phase: N/A
Study type: Observational

The purpose of this study is to collect kinematic motion data from subjects with movement disorders such as Parkinson's disease (PD) and essential tremor (ET) to develop and validate algorithms for quantifying motor symptoms such as tremor, bradykinesia (slowed movements), dyskinesias (sudden, involuntary movements), gait, and balance during standardized tasks and/or activities of daily living.